Sumitomo Mitsui Trust Holdings Inc. raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 2.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,267,316 shares of the medical research company’s stock after acquiring an additional 24,941 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.31% of Thermo Fisher Scientific worth $309,326,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. Pitcairn Co. grew its holdings in shares of Thermo Fisher Scientific by 1.3% during the second quarter. Pitcairn Co. now owns 16,871 shares of the medical research company’s stock worth $3,495,000 after buying an additional 215 shares in the last quarter. Hall Capital Management Co. Inc. grew its holdings in shares of Thermo Fisher Scientific by 6.2% during the third quarter. Hall Capital Management Co. Inc. now owns 3,780 shares of the medical research company’s stock worth $923,000 after buying an additional 220 shares in the last quarter. Nvwm LLC grew its holdings in shares of Thermo Fisher Scientific by 6.1% during the second quarter. Nvwm LLC now owns 4,231 shares of the medical research company’s stock worth $877,000 after buying an additional 242 shares in the last quarter. Tiedemann Advisors LLC grew its holdings in shares of Thermo Fisher Scientific by 19.4% during the second quarter. Tiedemann Advisors LLC now owns 1,518 shares of the medical research company’s stock worth $315,000 after buying an additional 247 shares in the last quarter. Finally, Chesapeake Wealth Management grew its holdings in shares of Thermo Fisher Scientific by 6.0% during the second quarter. Chesapeake Wealth Management now owns 4,393 shares of the medical research company’s stock worth $910,000 after buying an additional 249 shares in the last quarter. Hedge funds and other institutional investors own 85.41% of the company’s stock.

In other news, CEO Marc N. Casper sold 125,520 shares of the business’s stock in a transaction on Monday, October 1st. The shares were sold at an average price of $247.50, for a total transaction of $31,066,200.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.49% of the company’s stock.

Shares of TMO stock opened at $236.34 on Tuesday. The company has a market cap of $98.01 billion, a price-to-earnings ratio of 24.90, a price-to-earnings-growth ratio of 1.76 and a beta of 1.08. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.27 and a current ratio of 1.84. Thermo Fisher Scientific Inc. has a fifty-two week low of $181.51 and a fifty-two week high of $249.95.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, October 24th. The medical research company reported $2.62 earnings per share for the quarter, beating analysts’ consensus estimates of $2.55 by $0.07. The firm had revenue of $5.92 billion for the quarter, compared to analysts’ expectations of $5.70 billion. Thermo Fisher Scientific had a net margin of 10.75% and a return on equity of 16.49%. Thermo Fisher Scientific’s revenue was up 15.7% compared to the same quarter last year. During the same period in the previous year, the company posted $2.31 earnings per share. As a group, equities research analysts anticipate that Thermo Fisher Scientific Inc. will post 11.04 earnings per share for the current fiscal year.

Thermo Fisher Scientific declared that its board has approved a share repurchase program on Friday, September 7th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical research company to repurchase up to 2.1% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s management believes its stock is undervalued.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 15th. Stockholders of record on Monday, December 17th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Friday, December 14th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.29%. Thermo Fisher Scientific’s payout ratio is currently 7.17%.

A number of equities research analysts have recently commented on the stock. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $259.00 price target for the company in a report on Monday, July 30th. Leerink Swann lifted their price target on shares of Thermo Fisher Scientific from $239.00 to $255.00 and gave the stock an “outperform” rating in a report on Thursday, July 26th. Cleveland Research downgraded shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a report on Thursday, October 18th. Morgan Stanley boosted their target price on shares of Thermo Fisher Scientific from $254.00 to $260.00 and gave the company an “overweight” rating in a report on Thursday, October 25th. Finally, Robert W. Baird boosted their target price on shares of Thermo Fisher Scientific from $256.00 to $264.00 and gave the company an “outperform” rating in a report on Thursday, October 25th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Thermo Fisher Scientific presently has an average rating of “Buy” and a consensus price target of $261.45.

WARNING: “Sumitomo Mitsui Trust Holdings Inc. Acquires 24,941 Shares of Thermo Fisher Scientific Inc. (TMO)” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2018/11/13/sumitomo-mitsui-trust-holdings-inc-acquires-24941-shares-of-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Article: Penny Stocks

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.